I 
116TH CONGRESS 
2D SESSION 
H. R. 7288 
To direct the Secretary of Health and Human Services and other Federal 
officials to compile into a searchable database information relating to 
Federal support for biomedical research and development related to 
COVID–19, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 22, 2020 
Mr. DOGGETT (for himself, Mr. ROONEY of Florida, Ms. SCHAKOWSKY, Ms. 
DELAURO, Mr. DEFAZIO, Mr. POCAN, and Ms. JAYAPAL) introduced the 
following bill; which was referred to the Committee on Energy and Com-
merce, and in addition to the Committees on Armed Services, Veterans’ 
Affairs, Science, Space, and Technology, the Judiciary, and Ways and 
Means, for a period to be subsequently determined by the Speaker, in 
each case for consideration of such provisions as fall within the jurisdic-
tion of the committee concerned 
A BILL 
To direct the Secretary of Health and Human Services and 
other Federal officials to compile into a searchable data-
base information relating to Federal support for bio-
medical research and development related to COVID– 
19, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
00:29 Jul 11, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H7288.IH
H7288
kjohnson on DSK79L0C42PROD with BILLS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Taxpayer Research 
and Coronavirus Knowledge Act of 2020’’. 
SEC. 2. DATABASE. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services, the Director of the National Institutes 
of Health, the Assistant Secretary for Preparedness and 
Response of the Department of Health and Human Serv-
ices, the Director of the Biomedical Advanced Research 
and Development Authority, the Secretary of Defense, the 
Secretary of Veterans Affairs, the Director of the National 
Institute of Allergy and Infectious Diseases, and such 
other Federal officials as the Secretary of Health and 
Human Services determines to be relevant, acting in co-
ordination, shall— 
(1) compile into a searchable database informa-
tion relating to Federal support (before or after the 
date of enactment of this Act) for biomedical re-
search and development related to COVID–19 (in-
cluding biomedical research and development relat-
ing to a product or therapy that was later modified 
or repurposed to be used for COVID–19); and 
(2) make such database available on the public 
website of the Department of Health and Human 
Services. 
VerDate Sep 11 2014 
00:29 Jul 11, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H7288.IH
H7288
kjohnson on DSK79L0C42PROD with BILLS
(b) COVERED INFORMATION.—The information relat-
ing to Federal support referred to in subsection (a)(1) in-
cludes all contracts, funding agreements, licensing ar-
rangements, other transactions, and other arrangements 
entered into by the Federal Government and tax benefits 
provided with respect to research and development, and 
manufacturing, of a drug (including biological products), 
cell or gene therapy, or medical device intended to be man-
ufactured, 
used, 
designed, 
developed, 
modified, 
repurposed, licensed, or procured to diagnose, mitigate, 
prevent, treat, or cure COVID–19, including but not lim-
ited to the following: 
(1) Licensing agreements pursuant to section 
207 of title 35, United States Code. 
(2) Cooperative research and development 
agreements and licensing agreements pursuant to 
section 3710a of title 15, United States Code. 
(3) Funding agreements, as defined under sec-
tion 201 of title 35, United States Code. 
(4) Other transactions entered into pursuant to 
the following statutes: 
(A) Section 319L of the Public Health 
Service Act (42 U.S.C. 247d–7e). 
VerDate Sep 11 2014 
00:29 Jul 11, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H7288.IH
H7288
kjohnson on DSK79L0C42PROD with BILLS
(B) Section 105 of the National Institutes 
of Health Reform Act of 2006 (42 U.S.C. 
284n). 
(C) Section 480 of the Public Health Serv-
ice Act (42 U.S.C. 287a). 
(D) Section 421 of the Public Health Serv-
ice Act (42 U.S.C. 285b–3). 
(E) Section 2371 of title 10, United States 
Code. 
(5) Tax credits and deductions associated 
with— 
(A) qualified clinical testing expenses, as 
defined under section 45C of title 26, United 
States Code; 
(B) qualified research expenses, as defined 
under section 41 of title 26, United States 
Code; and 
(C) charitable contributions, as defined 
under section 170(c) of title 26, United States 
Code, to patient assistance programs. 
(c) INFORMATION REQUIRED.—Notwithstanding any 
other provision of law, the Federal officials referred to in 
subsection (a) shall include in the database under sub-
section (a), with regard to each contract, funding agree-
ment, licensing arrangement, other transaction, other ar-
VerDate Sep 11 2014 
00:29 Jul 11, 2020
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H7288.IH
H7288
kjohnson on DSK79L0C42PROD with BILLS